PROKIDNEY CORP. 8-K

What Happened
ProKidney Corp. (PROK) filed an 8-K on May 29, 2026 reporting the results of its May 28, 2026 Annual Meeting of Stockholders. Stockholders elected three director nominees—William F. Doyle, Alan M. Lotvin, M.D., and Brian J.G. Pereira—to three‑year terms (expiring at the 2029 annual meeting) and ratified Ernst & Young LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

Key Details

• Director election votes:
  • William F. Doyle: For 196,164,585; Withhold 1,459,235; Broker Non‑Votes 42,579,394.
  • Alan M. Lotvin, M.D.: For 193,179,768; Withhold 4,444,052; Broker Non‑Votes 42,579,394.
  • Brian J.G. Pereira: For 197,002,580; Withhold 621,240; Broker Non‑Votes 42,579,394.
• Auditor ratification: Ernst & Young LLP ratified as auditor for FY2026 — For 239,091,167; Against 729,165; Abstain 382,882; no broker non‑votes reported for this item.
• Report filed with the SEC on May 29, 2026.

Why It Matters
Board elections and auditor ratification are routine governance actions that confirm the company’s leadership and its choice of external auditor for the upcoming fiscal year. Investors can view the vote totals to assess shareholder support for management’s director slate and the auditor selection; ratification of EY means the company will proceed with EY as its independent auditor for 2026 audits and related reporting.